Literature DB >> 27634374

Erratum to: C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.

Toru Kimura1,2, Takashi Nojiri3,4, Jun Hino3, Hiroshi Hosoda5, Koichi Miura3, Yasushi Shintani4, Masayoshi Inoue6, Masahiro Zenitani3, Hiroyuki Takabatake3,4, Mikiya Miyazato3, Meinoshin Okumura4, Kenji Kangawa3.   

Abstract

Entities:  

Year:  2016        PMID: 27634374      PMCID: PMC5024475          DOI: 10.1186/s12931-016-0429-1

Source DB:  PubMed          Journal:  Respir Res        ISSN: 1465-9921


× No keyword cloud information.

Erratum

In the original publication of this article [1], the acknowledgements and contributions sections were incorrectly listed. These should have been: Author’s contributions Conception and Design: TK, TN, KK. Analysis and Interpretation: TK, TN, JH, HH, KM. Collecting the data: TK, JH, HH, KM, YS, MZ, HT. Drafting the manuscript for important intellectual content: TK, TN, JH, HH, KM, YS, MI. Obtaining the funding: TK, TN, MM, OM, KK. All authors have approved the version of the submitted manuscript. Acknowledgements We thank R. Weingerg for providing the hTERT immortalizing gene. We thank K. Sasai and T. Akagi for providing the lentivirus vector expressing hTERT. This work was supported in part by Grant-in-Aid for Young Scientists B (26861135) and the Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center to T. Kimura, Japan Research Foundation for Clinical Pharmacology, Kobayashi Foundation for Cancer Research, Mochida Memorial Foundation for Medical and Pharmaceutical Research, Uehara Memorial Foundation, and Takeda Science Foundation to T. Nojiri, Grant‐in‐Aid for Scientific Research on Innovative Areas (Research in a proposed research area) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Japan Vascular Disease Research Foundation to K. Kangawa.
  1 in total

1.  C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.

Authors:  Toru Kimura; Takashi Nojiri; Jun Hino; Hiroshi Hosoda; Koichi Miura; Yasushi Shintani; Masayoshi Inoue; Masahiro Zenitani; Hiroyuki Takabatake; Mikiya Miyazato; Meinoshin Okumura; Kenji Kangawa
Journal:  Respir Res       Date:  2016-02-19
  1 in total
  1 in total

1.  Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients.

Authors:  Antonio Vitiello; Francesco Ferrara
Journal:  Wien Klin Wochenschr       Date:  2021-04-20       Impact factor: 2.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.